Versant Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-87
| Closed | -$399 | – | 2736 |
|
|
2025
Q1 | $399 | Sell |
87
-484
| -85% | -$2.22K | ﹤0.01% | 2427 |
|
|
2024
Q4 | $2.74K | Buy |
571
+547
| +2,279% | +$2.62K | ﹤0.01% | 1982 |
|
|
2024
Q3 | $113 | Hold |
24
| – | – | ﹤0.01% | 1982 |
|
|
2024
Q2 | $136 | Hold |
24
| – | – | ﹤0.01% | 1922 |
|
|
2024
Q1 | $99 | Sell |
24
-238
| -91% | -$982 | ﹤0.01% | 1862 |
|
|
2023
Q4 | $1.11K | Buy |
262
+22
| +9% | +$93 | ﹤0.01% | 1483 |
|
|
2023
Q3 | $1.04K | Buy |
240
+66
| +38% | +$285 | ﹤0.01% | 1515 |
|
|
2023
Q2 | $1.15K | Hold |
174
| – | – | ﹤0.01% | 1552 |
|
|
2023
Q1 | $1.17K | Sell |
174
-661
| -79% | -$4.44K | ﹤0.01% | 1405 |
|
|
2022
Q4 | $6.17K | Sell |
835
-27
| -3% | -$200 | ﹤0.01% | 812 |
|
|
2022
Q3 | $9K | Buy |
862
+5
| +0.6% | +$52 | ﹤0.01% | 690 |
|
|
2022
Q2 | $9K | Buy |
857
+109
| +15% | +$1.15K | ﹤0.01% | 702 |
|
|
2022
Q1 | $8K | Sell |
748
-37
| -5% | -$396 | ﹤0.01% | 760 |
|
|
2021
Q4 | $12K | Buy |
785
+34
| +5% | +$520 | ﹤0.01% | 672 |
|
|
2021
Q3 | $13K | Sell |
751
-91
| -11% | -$1.58K | ﹤0.01% | 628 |
|
|
2021
Q2 | $18K | Sell |
842
-366
| -30% | -$7.82K | 0.01% | 523 |
|
|
2021
Q1 | $18K | Buy |
1,208
+147
| +14% | +$2.19K | 0.01% | 596 |
|
|
2020
Q4 | $13K | Buy |
1,061
+7
| +0.7% | +$86 | 0.01% | 660 |
|
|
2020
Q3 | $10K | Buy |
1,054
+270
| +34% | +$2.56K | ﹤0.01% | 669 |
|
|
2020
Q2 | $8K | Sell |
784
-122
| -13% | -$1.25K | ﹤0.01% | 712 |
|
|
2020
Q1 | $9K | Buy |
+906
| New | +$9K | ﹤0.01% | 595 |
|